title: Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease.
abstract: Understanding the pathogenesis of infectious disease requires the examination and successful integration of parameters related to both microbial virulence and host responses. As a practical and powerful method to control microbial gene expression, including in vivo, the tetracycline-regulatable system has recently gained the favor of many investigative groups. However, some immunomodulatory effects of the tetracyclines, including doxycycline, could potentially limit its use to evaluate host responses during infection. Here we have used a well-established murine model of disseminated candidiasis, which is highly dependent on both the virulence displayed by the fungal cells and on the host immune status, to validate the use of this system. We demonstrate that the pathogenesis of the wild type C. albicans CAF2-1 strain, which does not contain any tet-regulatable element, is not affected by the presence of doxycycline. Moreover levels of key cytokines, chemokines and many other biomarkers, as determined by multi-analyte profiling, remain essentially unaltered by the presence of the antibiotic during infection. Our results indicate that the levels of doxycycline needed to control the tetracycline regulatable promoter gene expression system have no detectable effect on global host responses during candidiasis. Because tet-regulatable systems are now being increasingly used in a variety of pathogenic microorganisms, these observations have wide implications in the field of infectious diseases.
authors.affiliation: Department of Biology and South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, Texas, United States of America.
authors.forename: Ashok K
authors.initials: AK
authors.lastname: Chaturvedi
authors.forename: Anna L
authors.initials: AL
authors.lastname: Lazzell
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Saville
authors.forename: Floyd L
authors.initials: FL
authors.lastname: Wormley
authors.forename: Carlos
authors.initials: C
authors.lastname: Monteagudo
authors.forename: Jose L
authors.initials: JL
authors.lastname: Lopez-Ribot
mesh_terms: D000818:Animals; D002176:Candida albicans / Q000235:genetics* / Q000472:pathogenicity / Q000502:physiology; D002177:Candidiasis / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology; D018925:Chemokines / Q000097:blood / Q000276:immunology / Q000378:metabolism; D016207:Cytokines / Q000097:blood / Q000276:immunology / Q000378:metabolism; D004195:Disease Models, Animal; D004318:Doxycycline / Q000494:pharmacology; D015966:Gene Expression Regulation, Fungal / Q000187:drug effects*; D054884:Host-Pathogen Interactions / Q000187:drug effects; D007668:Kidney / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D051379:Mice; D009154:Mutation; D011401:Promoter Regions, Genetic / Q000235:genetics; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D020218:Response Elements / Q000235:genetics; D013154:Spleen / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D013752:Tetracycline / Q000494:pharmacology*; D014774:Virulence / Q000235:genetics
chemical_list: D018925:Chemokines; D016207:Cytokines; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline; D004318:Doxycycline